Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05897021 · ClinicalTrials.gov registry record · NA
Expressive Writing on Minority Stressors Among Sexual Minority Veterans
A NA study of Anxiety and Depressive Symptoms, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 1
- Study location
NCT05897021 is a NA study of Anxiety and Depressive Symptoms that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 85 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05897021, a NA study of Anxiety and Depressive Symptoms, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
Sexual minority stressors (e.g., sexual minority identity-based discrimination) contribute to greater risk for and severity of depression, anxiety, substance use disorders and suicide among sexual minority Veterans. However, no brief, scalable, one-on-one interventions targeting sexual minority stressor-related distress are available in Veterans Affairs (VA) for sexual minority Veterans. The proposed research will examine the feasibility, acceptability, and preliminary effectiveness of a brief, 3-session expressive writing intervention to target distress related to sexual minority stressor exposure among sexual minority Veterans. The results of this work will advance knowledge about a promising brief and easy to implement intervention focused on reducing depressive and anxiety symptoms among sexual minority Veterans. This proposal aligns with VA's and CSR\&D's commitment to providing equitable services to sexual minority Veterans and the aim of reducing health disparities among underserved Veteran groups.
Conditions Studied
Interventions
- BEHAVIORAL Neutral Writing
- BEHAVIORAL Expressive Writing on Minority Stressors
Study Locations (1)
Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2024-03-20 |
| Est. Completion | 2028-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05897021
The ClinicalTrials.gov registry entry for NCT05897021 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (81% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Neutral Writing is the first listed.
NCT05897021 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05897021 about?
NCT05897021 is a clinical study titled "Expressive Writing on Minority Stressors Among Sexual Minority Veterans". Sexual minority stressors (e.g., sexual minority identity-based discrimination) contribute to greater risk for and severity of depression, anxiety, substance use disorders and suicide among sexual minority Veterans. However, no brief, scalable, one-on-one interventions targeting sexual minority stre...
What is the current status of trial NCT05897021?
This trial is currently recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2024-03-20. Estimated completion is 2028-09-30.
What conditions does trial NCT05897021 study?
This clinical trial studies the following conditions: Anxiety, Depressive Symptoms.
What interventions are being tested in trial NCT05897021?
The interventions under investigation include: Neutral Writing (BEHAVIORAL), Expressive Writing on Minority Stressors (BEHAVIORAL).
Who is sponsoring clinical trial NCT05897021?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05897021 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.